BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 19566653)

  • 1. Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice.
    Gordon EJ; Kelkar V
    Xenotransplantation; 2009; 16(3):135-44. PubMed ID: 19566653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both innate and adaptive major histocompatibility complex class I-dependent immunity impair long-term islet xenograft survival.
    Ramirez-Victorino F; Beilke JN; Gill RG
    Transplant Proc; 2008 Mar; 40(2):557-8. PubMed ID: 18374128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
    Beilke J; Johnson Z; Kuhl N; Gill RG
    Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice.
    Ikehara Y; Yasunami Y; Kodama S; Maki T; Nakano M; Nakayama T; Taniguchi M; Ikeda S
    J Clin Invest; 2000 Jun; 105(12):1761-7. PubMed ID: 10862791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Kobayashi N; Nomoto K; Kong YY; Nomoto K
    Immunology; 1994 Oct; 83(2):196-204. PubMed ID: 7835935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cells promote islet allograft tolerance via a perforin-dependent mechanism.
    Beilke JN; Kuhl NR; Van Kaer L; Gill RG
    Nat Med; 2005 Oct; 11(10):1059-65. PubMed ID: 16155578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
    Masaki H; Appel MC; Leahy L; Leif J; Paquin L; Shultz LD; Mordes JP; Greiner DL; Rossini AA
    Xenotransplantation; 2006 May; 13(3):224-32. PubMed ID: 16756565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
    Koulmanda M; Laufer TM; Auchincloss H; Smith RN
    Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct requirements for host CD80/CD86 costimulatory molecules in cardiac versus islet rejection.
    Johnson Z; Beilke J; Pietra B; Kelly B; Gill RG
    Transplant Proc; 2004 May; 36(4):1171-2. PubMed ID: 15194405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of NKT cells in allogeneic islet graft survival.
    Yang SH; Jin JZ; Lee SH; Park H; Kim CH; Lee DS; Kim S; Chung NH; Kim YS
    Clin Immunol; 2007 Sep; 124(3):258-66. PubMed ID: 17662658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cells promote peritoneal xenograft rejection through an IFN-gamma-dependent mechanism.
    Lin ML; Zhan Y; Nutt SL; Brady J; Wojtasiak M; Brooks AG; Lew AM
    Xenotransplantation; 2006 Nov; 13(6):536-46. PubMed ID: 17059581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
    Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts.
    Markmann JF; Campos L; Bhandoola A; Kim JI; Desai NM; Bassiri H; Claytor BR; Barker CF
    Surgery; 1994 Aug; 116(2):242-8; discussion 248-9. PubMed ID: 8047991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
    Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer T-cells participate in rejection of islet allografts in the liver of mice.
    Toyofuku A; Yasunami Y; Nabeyama K; Nakano M; Satoh M; Matsuoka N; Ono J; Nakayama T; Taniguchi M; Tanaka M; Ikeda S
    Diabetes; 2006 Jan; 55(1):34-9. PubMed ID: 16380474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of porcine islet xenografts in mice using sertoli cells and monoclonal antibodies.
    Ramji QA; Bayrack K; Arefanian H; Marcet-Palacios M; Bleackley RC; Rajotte RV; Rayat GR
    Transplantation; 2011 Dec; 92(12):1309-15. PubMed ID: 22037619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac and skin xenograft survival in different recipient mouse strains.
    Gock H; Murray-Segal L; Salvaris E; Fisicaro N; Cowan PJ; d'Apice AJ
    Transplantation; 2006 Nov; 82(10):1362-9. PubMed ID: 17130786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.